Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.


Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.

● The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Sales forecast by analysts have been recently revised upwards.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● Analyst opinion has improved significantly over the past four months.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.


Weaknesses

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 207.65 times its estimated earnings per share for the ongoing year.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.